National Heart Institute
Institut Jantung Negara (IJN) is Malaysia's 437-bed National Heart Institute, a quaternary cardiovascular and thoracic specialty hospital in Kuala Lumpur operating five Centres of Excellence with 200+ specialist doctors and serving both domestic patients and regional medical tourists across Southeast Asia.
- Company typePrivate
- Founded1992
- HeadquartersKuala Lumpur, Malaysia
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What National Heart Institute does
Institut Jantung Negara (IJN), operating as Malaysia's National Heart Institute, is a 437-bed quaternary cardiovascular and thoracic specialty hospital established on 1 August 1992 in Kuala Lumpur by the Malaysian government and registered as Institut Jantung Negara Sdn Bhd. It organizes its clinical portfolio around five Centers of Excellence: Cardiology, Cardiothoracic and Vascular Surgery, Paediatrics and Congenital Heart Centre (PCHC, est. 2012), Diagnostic Imaging, and Heart Failure, supported by IJN First Pharmacy, a Renal Dialysis Unit (18 beds), a Health Screening/Wellness Centre, and IJN University College. The clinical infrastructure comprises 9 operating theatres (including 1 hybrid OT), 68 consultation clinics, 8 invasive cardiac laboratories, and 200+ specialist doctors, with a cumulative track record of nearly 81,000 cardiothoracic and vascular surgeries over 22 years and over 3.7 million patients treated since inception.
Technology stack centers on a HIMSS EMRAM Stage 7-certified electronic health record (first in Malaysia, validated March 2026), powered by Medicomp's Quippe clinical documentation platform with 98% electronic documentation adoption, advanced clinical decision support, and closed-loop medication management. Diagnostic imaging includes a 512-slice CT scanner, cardiac MRI, PET-CT with Rubidium-82 cardiac perfusion, and SPECT. The hospital offers advanced procedures including Valve-Sparing Root Replacement (VSRR), TAVI, MitraClip, Renal Denervation Therapy, and EKOS for pulmonary embolism. It holds dual JCI Centre of Excellence accreditations (Heart Failure Program and Ventricular Septal Defect Management) — both firsts in Malaysia — alongside general JCI accreditation.
Revenue is generated through fee-for-service cardiac care (consultations, diagnostics, interventional procedures, surgery, inpatient care), pharmacy dispensing (IJN First Pharmacy, including home delivery), international patient services (medical tourism), and ancillary administrative fees (medical reports RM50-250, deposits RM500). Customer segments span adult cardiac patients, pediatric/congenital heart patients, insured patients (panel providers include Prudential, Great Eastern, AIA, Allianz), government-funded patients via guarantee letters, and international medical tourists from Indonesia, Myanmar, Vietnam, Cambodia, and Bangladesh. International growth is a strategic priority: the International Patient Centre and overseas representative offices handle visa assistance, airport transfers, and interpreter services, with hotel partners (Renaissance, EQ, Element, Sunway Putra) and MHTC-driven campaigns (Malaysia Year of Medical Tourism 2026) supporting demand. Disclosed revenue from Cambodian health travelers reached RM30.3M in 2025 (12,000+ patients) and Bangladeshi health tourists generated a record RM10.4M as of February 2026 (10,800+ patients).
National Heart Institute firmographics
Firmographics- Name
- National Heart Institute
- Legal name
- Institut Jantung Negara
- Website
- https://ijn.com.my
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Institut Jantung Negara (IJN) is Malaysia's 437-bed National Heart Institute, a quaternary cardiovascular and thoracic specialty hospital in Kuala Lumpur operating five Centres of Excellence with 200+ specialist doctors and serving both domestic patients and regional medical tourists across Southeast Asia.
- Ownership category
- akta.pro rank
National Heart Institute industry classification
Industry- Product category
- Specialty Cardiac Hospital Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Diagnostic Imaging Centers (621512)
- SIC
- Services-Hospitals (8060), Services-Health Services (8000)
- akta.pro primary industry
- Cardiac & Cardiothoracic Specialty Hospitals (HLAFAHAA)
- akta.pro secondary industries
- Cardiovascular / Cath Lab & Electrophysiology Centers (HLAFAIAI), Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear) (HLAKABAE), Interventional Cardiology (PCI/Structural Heart) (HLAKABAB), Cardiac & Complex Care Medical Travel Agencies (THAKAIAH), Heart Failure & Transplant Cardiology (HLAKABAD)
Keywords
Where National Heart Institute is headquartered
LocationHeadquarters
- HQ city
- Kuala Lumpur
- HQ country
- Malaysia
- HQ region
- Asia
Offices5 records
Markets served
National Heart Institute business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Healthcare Services Revenue: Revenue from consultations, diagnostic services, surgical procedures, inpatient care, and outpatient treatments across cardiology, cardiothoracic surgery, and pediatric cardiac services
- Pharmacy Services: IJN First Pharmacy provides dispensing of prescription medicines, over-the-counter products, diagnostic devices, nutritional supplements, and home delivery services
- International Patient Services: Medical tourism revenue from international patients seeking cardiovascular care, with dedicated IPC services including visa coordination, accommodation assistance, and interpreter services
- Medical Report and Administrative Services: Fees for medical reports, insurance claim forms, EPF incapacitation documentation, and administrative processing services
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Attending Physician Statement by Consultant: RM120 |
| Unit Pricing | Pay-as-you-go | 5-star hotel partnerships ranging from RM320-RM540 per night |
| Unit Pricing | Pay-as-you-go | Self-paying deposit: RM500 for new cases (balance refundable) |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels5 records
National Heart Institute product offering
Product offeringCore offering
National Heart Institute is a quaternary specialty hospital focused on cardiovascular and thoracic care. It delivers diagnostic, interventional, surgical, and rehabilitative cardiac services to adult and pediatric patients, and operates dedicated medical-tourism infrastructure for international patients. The core revenue-generating activities are inpatient admissions, cardiac procedures and surgeries, outpatient specialist consultations, and diagnostic imaging.
Product overview
The National Heart Institute (Institut Jantung Negara, IJN) is a 437-bed quaternary cardiovascular and thoracic specialty hospital established on 1 August 1992, offering a multi-specialty portfolio organised around five Centres of Excellence: Cardiology (with JCI-accredited Heart Failure and VSD programmes), Cardiothoracic & Vascular Surgery, Paediatrics & Congenital Heart Centre, and Diagnostic Imaging. These clinical centres are supported by an on-site pharmacy (IJN First Pharmacy), Renal Dialysis Unit, Health Screening/Wellness Centre, International Patient Centre for medical tourism, IJN University College for education, and a Clinical Research Program. With 9 operating theatres (including 1 hybrid), 68 consultation clinics, 8 invasive cardiac laboratories, and over 3.7 million patients treated to date, IJN positions itself as Malaysia's premier heart specialist centre and a leading medical tourism destination in Asia.
Differentiator
Problem solved
Functional benefit
Brands
- Paediatric & Congenital Heart Centre (PCHC): A dedicated unit set up in September 2012 providing comprehensive care for babies, children, and adolescents with heart disease as well as adults with congenital heart disease, functioning as a one-stop centre for all paediatric and congenital heart needs.
- IJN First Pharmacy
Products and services
- Adult Cardiology Services Comprehensive diagnostic, interventional, and medical management of adult cardiovascular conditions, delivered to outpatient and inpatient adult patients.
- Cardiac Surgery Surgical treatment of heart disease including coronary artery bypass, valve repair and replacement, and other open-heart procedures for adult cardiac patients.
- Pediatric Cardiac Care Diagnostic, interventional, and surgical care for infants and children with congenital and acquired heart disease.
- Thoracic Surgery Surgical management of diseases of the chest, lungs, esophagus, and mediastinum for patients referred for thoracic intervention.
- Interventional Cardiology Catheter-based procedures such as angioplasty and stenting delivered through the cardiac catheterization laboratory for adult and select patients.
- Diagnostic Imaging Services Cardiac and thoracic diagnostic imaging using modalities including PET-CT and a 512-slice CT scanner, supporting disease diagnosis, staging, and procedural planning.
- Medical Tourism Program Dedicated service program for international patients combining cardiac treatment with accommodation, language support, and overseas referral coordination via representative offices and partner hotels.
Quantifiable outcome
- 98% adoption of electronic clinical documentation
- +4 more outcomes
Companies that use National Heart Institute
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles4 records
National Heart Institute technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
National Heart Institute partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core, strategic and minor.
- Malaysia Healthcare Travel Council (MHTC)coreIJN participates in Malaysia Healthcare Expo (MHX) and Malaysia Healthcare Week events organized by MHTC as part of Malaysia Year of Medical Tourism 2026 campaign, promoting Malaysia as preferred healthcare destination for international patients
- OneHealth CambodiastrategicStrategic partnership for cross-border healthcare collaboration strengthening Malaysia-Cambodia healthcare connections for medical tourism
- Medicomp SystemscoreMedicomp's Quippe clinical documentation platform enabled IJN to become Malaysia's first hospital to achieve HIMSS EMRAM Stage 7 validation, achieving 98% adoption of electronic clinical documentation, advanced clinical decision support, and closed-loop medication management
- APUK Co., Ltd.coreRegional implementation partner for Medicomp Systems, working alongside IJN to accomplish HIMSS EMRAM Stage 7 certification milestone
- PT Pertamina Bina Medika IHCstrategicIndonesian hospital/medical partner for international patient referrals and healthcare collaboration
- RS Jantung Harapan KitastrategicIndonesian cardiac hospital partnership for patient referrals and medical collaboration
- Oriental Bank PlcminorBank partner for international patient financial services in Cambodia
- Public Bank CambodiaminorBank partner for international patient financial services in Cambodia
- Renaissance Kuala Lumpur Hotelminor5-star hotel partner located 2.5KM from IJN with rates from RM429 per night, providing accommodation options for international patients and families
- IJN University CollegestrategicAffiliated educational institution for training and development in cardiovascular and healthcare disciplines
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
National Heart Institute competitors and assessment
Company assessmentBroad incumbents
- Bangkok Hospital (BDMS): BDMS flagship offering cardiology, cardiothoracic surgery, and complex tertiary care with strong regional medical tourism flows from Southeast Asia and the Middle East. Competes with IJN for international cardiology patients, particularly from Cambodia and Myanmar.
- Cleveland Clinic Abu Dhabi: US-branded quaternary specialty hospital in the Middle East with a comprehensive heart, vascular and thoracic institute. Comparable to IJN on quaternary cardiac capability and accreditation-driven international medical tourism positioning, though at a higher acuity tier.
- Bumrungrad International Hospital: Thailand's largest medical tourism-focused private tertiary/quaternary hospital serving international patients across cardiology and multiple specialties. Comparable to IJN on international patient acquisition capability and the MHTC/medical tourism value proposition, though broader in clinical scope.
- KPJ Healthcare Berhad: Malaysia's largest private hospital network with multiple specialist facilities offering cardiology services domestically. Competes with IJN for Malaysian private and insured cardiac volumes, though not as concentrated a cardiac specialty play.
- Apollo Hospitals Enterprise: India's largest private hospital chain with strong cardiac surgery volumes and a well-developed international patient program targeting SAARC and Southeast Asian markets. Comparable to IJN as a regional cardiac care destination, particularly for Bangladesh-sourced patients.
- Gleneagles Hospital Kuala Lumpur: Premier private tertiary hospital in Kuala Lumpur offering cardiology and cardiothoracic services to both local and international patients. IHH-managed; competes with IJN within the same city for private-paying and insured cardiac cases.
Regional players
- Samitivej Hospital (Bangkok Dusit Medical Services): BDMS-affiliated Bangkok hospital with a strong Japanese and Southeast Asian medical tourism franchise, including cardiology services. Represents another competitor for cross-border cardiac patient flows in ASEAN that IJN targets.
Direct peers
- Asian Heart Institute: Mumbai-based dedicated cardiac hospital offering complex cardiac surgery, interventional cardiology, and heart failure management with a strong reputation for high-acuity cases. Directly comparable in scope and business model to IJN's cardiac specialty positioning.
- National Heart Centre Singapore (NHCS): Singapore's national specialty cardiac hospital offering the same quaternary cardiovascular and cardiothoracic services as IJN, including adult and pediatric cardiac surgery, interventional cardiology, and heart failure management. The closest geographic and clinical peer for IJN, competing for the same Southeast Asian patient base.
- Fortis Escorts Heart Institute: One of India's premier dedicated cardiac specialty hospitals, performing high volumes of cardiac surgery, interventional cardiology, and pediatric cardiac procedures. Comparable to IJN as a single-specialty quaternary cardiac center with strong medical tourism inflows from South Asia.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
National Heart Institute social profiles
Digital presenceNational Heart Institute compliance and trust
Trust signalCompliance5 records
National Heart Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
National Heart Institute leadership team
Management profileNumber of profiles
National Heart Institute subsidiaries and ownership
Company hierarchySubsidiaries1 record
National Heart Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
National Heart Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about National Heart Institute
What does National Heart Institute do?
National Heart Institute is a quaternary specialty hospital focused on cardiovascular and thoracic care. It delivers diagnostic, interventional, surgical, and rehabilitative cardiac services to adult and pediatric patients, and operates dedicated medical-tourism infrastructure for international patients. The core revenue-generating activities are inpatient admissions, cardiac procedures and surgeries, outpatient specialist consultations, and diagnostic imaging.
Is National Heart Institute a public or private company?
National Heart Institute is a private company. It is classified as unknown and is currently operating.
When was National Heart Institute founded?
National Heart Institute was founded in 1992. It employs 1,001 to 5,000 people.
Where is National Heart Institute based?
National Heart Institute is headquartered in Kuala Lumpur, Malaysia, in the Asia region.
How does National Heart Institute make money?
Four revenue lines are on record. Healthcare Services Revenue is the primary driver. The others are pharmacy Services, international Patient Services and medical Report and Administrative Services.
Who are National Heart Institute's main competitors?
Broad incumbents on record are Bangkok Hospital (BDMS), Cleveland Clinic Abu Dhabi, Bumrungrad International Hospital, KPJ Healthcare Berhad, Apollo Hospitals Enterprise and Gleneagles Hospital Kuala Lumpur. Samitivej Hospital (Bangkok Dusit Medical Services) is listed as a regional player. Direct peers are Asian Heart Institute, National Heart Centre Singapore (NHCS) and Fortis Escorts Heart Institute.
Does National Heart Institute have an API?
No public API is recorded for National Heart Institute.
What industry is National Heart Institute in?
National Heart Institute's product category is Specialty Cardiac Hospital Services. Its primary akta.pro industry code is HLAFAHAA, Cardiac & Cardiothoracic Specialty Hospitals, with a secondary code of HLAFAIAI, Cardiovascular / Cath Lab & Electrophysiology Centers. Its NAICS code is 622310 and its SIC code is 8060.